111 Inc. - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About 111 Inc. - ADR
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People’s Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
Frequently asked questions
To buy 111 Inc. - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for 111 Inc. - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for 111 Inc. - ADR is YI:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
111 Inc. - ADR has its primary listing on NASDAQ. You can trade 111 Inc. - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, 111 Inc. - ADR is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include 111 Inc. - ADR as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like 111 Inc. - ADR.